Disease-Associated Neurotoxic Astrocyte Markers in Alzheimer Disease Based on Integrative Single-Nucleus RNA Sequencing

Wuhan Yu,Yin Li,Fuxin Zhong,Zhangjing Deng,Jiani Wu,Weihua Yu,Yang Lü

DOI: https://doi.org/10.1007/s10571-024-01453-w

2024-02-13

Cellular and Molecular Neurobiology

Abstract:Alzheimer disease (AD) is an irreversible neurodegenerative disease, and astrocytes play a key role in its onset and progression. The aim of this study is to analyze the characteristics of neurotoxic astrocytes and identify novel molecular targets for slowing down the progression of AD. Single-nucleus RNA sequencing (snRNA-seq) data were analyzed from various AD cohorts comprising about 210,654 cells from 53 brain tissue. By integrating snRNA-seq data with bulk RNA-seq data, crucial astrocyte types and genes associated with the prognosis of patients with AD were identified. The expression of neurotoxic astrocyte markers was validated using 5 × FAD and wild-type (WT) mouse models, combined with experiments such as western blot, quantitative real-time PCR (qRT-PCR), and immunofluorescence. A group of neurotoxic astrocytes closely related to AD pathology was identified, which were involved in inflammatory responses and pathways related to neuron survival. Combining snRNA and bulk tissue data, ZEP36L, AEBP1, WWTR1, PHYHD1, DST and RASL12 were identified as toxic astrocyte markers closely related to disease severity, significantly elevated in brain tissues of 5 × FAD mice and primary astrocytes treated with Aβ. Among them, WWTR1 was significantly increased in astrocytes of 5 × FAD mice, driving astrocyte inflammatory responses, and has been identified as an important marker of neurotoxic astrocytes. snRNA-seq analysis reveals the biological functions of neurotoxic astrocytes. Six genes related to AD pathology were identified and validated, among which WWTR1 may be a novel marker of neurotoxic astrocytes.

neurosciences,cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the characteristics of neurotoxic astrocytes in Alzheimer's disease (AD) and their relationship with disease progression. Specifically, the study aims to analyze the properties of neurotoxic astrocytes and identify novel molecular targets related to AD pathology by integrating single - nucleus RNA sequencing (snRNA - seq) data, with the hope of slowing down the progression of AD. The research focuses on:

1. **Analysis of the characteristics of neurotoxic astrocytes**:
- Using snRNA - seq technology, analyze the data of approximately 210,654 cells from multiple AD cohorts to identify astrocyte types and genes related to the prognosis of AD patients.
- Determine key astrocyte types and genes by integrating snRNA - seq data and bulk RNA - seq data.

2. **Validation of neurotoxic astrocyte markers**:
- Use the 5×FAD mouse model and the wild - type (WT) mouse model, combined with Western blot, quantitative real - time PCR (qRT - PCR) and immunofluorescence experiments, to validate the expression of neurotoxic astrocyte markers.
- Identify a group of neurotoxic astrocytes closely related to AD pathology, which are involved in inflammatory response and neuron survival - related pathways.

3. **Identification of new molecular targets**:
- Combine snRNA - seq and bulk tissue data to identify ZEP36L, AEBP1, WWTR1, PHYHD1, DST and RASL12 as toxic astrocyte markers closely related to disease severity.
- In particular, WWTR1 is significantly increased in astrocytes of 5×FAD mice, driving the inflammatory response of astrocytes and is identified as an important neurotoxic astrocyte marker.

Through these studies, the authors hope to provide new insights into the mechanism of action of astrocytes in AD and potential molecular targets for the development of treatment strategies.